Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Jialu Xu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Cell|February 22, 2023
Till SMARCA5 loss do nucleosomes partJane Jialu Xu, Aaron D Viny
Experimental Hematology|April 6, 2024
Chromatin organization in myelodysplastic syndromeJane Jialu Xu, Aaron D Viny
Experimental Hematology|November 9, 2018
Modeling human RNA spliceosome mutations in the mouse: not all mice were created equalJane Jialu Xu, Monique F Smeets, Shuh Ying Tan, et al.
Leukemia|October 21, 2022
Srsf2<sup>P95H/+</sup> co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia-like disease in miceJane Jialu Xu, Alistair M Chalk, Meaghan Wall, et al.
Blood Advances|August 31, 2021
Genome-wide screening identifies cell-cycle control as a synthetic lethal pathway with SRSF2P95H mutationJane Jialu Xu, Alistair M Chalk, Iva Nikolic, et al.
Blood|June 16, 2018
<i>Srsf2</i><i></i> initiates myeloid bias and myelodysplastic/myeloproliferative syndrome from hemopoietic stem cellsMonique F Smeets, Shuh Ying Tan, Jane Jialu Xu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Cell|February 22, 2023
Till SMARCA5 loss do nucleosomes partJane Jialu Xu, Aaron D Viny
Experimental Hematology|April 6, 2024
Chromatin organization in myelodysplastic syndromeJane Jialu Xu, Aaron D Viny
Experimental Hematology|November 9, 2018
Modeling human RNA spliceosome mutations in the mouse: not all mice were created equalJane Jialu Xu, Monique F Smeets, Shuh Ying Tan, et al.
Leukemia|October 21, 2022
Srsf2<sup>P95H/+</sup> co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia-like disease in miceJane Jialu Xu, Alistair M Chalk, Meaghan Wall, et al.
Blood Advances|August 31, 2021
Genome-wide screening identifies cell-cycle control as a synthetic lethal pathway with SRSF2P95H mutationJane Jialu Xu, Alistair M Chalk, Iva Nikolic, et al.
Blood|June 16, 2018
<i>Srsf2</i><i></i> initiates myeloid bias and myelodysplastic/myeloproliferative syndrome from hemopoietic stem cellsMonique F Smeets, Shuh Ying Tan, Jane Jialu Xu, et al.
Pageof 1